| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 37.55B | 15.43B | 14.54B | 29.70B | 23.86B |
| Gross Profit | 14.37B | 15.43B | 44.25B | 17.27B | 15.82B |
| EBITDA | 5.12B | 0.00 | 6.13B | 5.82B | 7.11B |
| Net Income | 3.50B | 4.61B | 4.12B | 4.36B | 5.27B |
Balance Sheet | |||||
| Total Assets | 920.99B | 877.76B | 860.36B | 882.83B | 907.47B |
| Cash, Cash Equivalents and Short-Term Investments | 54.58B | 41.30B | 89.59B | 112.15B | 120.64B |
| Total Debt | 29.37B | 53.42B | 53.37B | 51.16B | 58.95B |
| Total Liabilities | 815.36B | 772.02B | 752.03B | 786.57B | 805.39B |
| Stockholders Equity | 105.33B | 105.46B | 97.97B | 95.99B | 101.78B |
Cash Flow | |||||
| Free Cash Flow | 6.52B | -8.28B | -17.60B | 9.86B | 1.71B |
| Operating Cash Flow | 6.92B | -7.74B | -16.92B | 10.41B | 2.32B |
| Investing Cash Flow | -39.91B | -318.00M | -511.00M | 2.13B | 2.67B |
| Financing Cash Flow | 38.81B | 4.94B | -1.74B | -31.28B | 41.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.17T | 8.32 | 11.95% | 4.26% | -4.57% | 1.77% | |
71 Outperform | HK$462.45B | 10.39 | 11.77% | 5.80% | 1.90% | 12.81% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$18.08B | 2.17 | 6.51% | 6.54% | ― | ― | |
66 Neutral | HK$506.25B | 5.02 | 9.01% | 5.76% | -5.46% | 0.33% | |
64 Neutral | HK$36.78B | 10.03 | 3.26% | 5.78% | -7.68% | 49.57% | |
57 Neutral | HK$210.57B | 5.64 | 6.61% | 5.53% | -8.41% | -5.52% |